Bio-Path Holdings Inc (BPTH)
2.15
-0.43
(-16.67%)
USD |
NASDAQ |
May 15, 15:58
Bio-Path Holdings Cash from Operations (Quarterly): -1.814M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.814M |
| September 30, 2023 | -2.781M |
| June 30, 2023 | -3.287M |
| March 31, 2023 | -3.653M |
| December 31, 2022 | -5.00M |
| September 30, 2022 | -3.374M |
| June 30, 2022 | -4.203M |
| March 31, 2022 | -2.526M |
| December 31, 2021 | -2.801M |
| September 30, 2021 | -2.891M |
| June 30, 2021 | -2.653M |
| March 31, 2021 | -1.572M |
| December 31, 2020 | -2.592M |
| September 30, 2020 | -2.353M |
| June 30, 2020 | -3.48M |
| March 31, 2020 | -2.535M |
| December 31, 2019 | -2.245M |
| September 30, 2019 | -1.893M |
| June 30, 2019 | -2.215M |
| March 31, 2019 | -2.008M |
| December 31, 2018 | -1.283M |
| September 30, 2018 | -1.471M |
| June 30, 2018 | -1.706M |
| March 31, 2018 | -1.664M |
| December 31, 2017 | -2.225M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.529M |
| June 30, 2017 | -2.363M |
| March 31, 2017 | -1.84M |
| December 31, 2016 | -1.611M |
| September 30, 2016 | -1.907M |
| June 30, 2016 | -2.249M |
| March 31, 2016 | -2.381M |
| December 31, 2015 | -1.001M |
| September 30, 2015 | -1.225M |
| June 30, 2015 | -1.374M |
| March 31, 2015 | -1.405M |
| December 31, 2014 | -1.156M |
| September 30, 2014 | -1.018M |
| June 30, 2014 | -1.099M |
| March 31, 2014 | -0.5444M |
| December 31, 2013 | -0.4768M |
| September 30, 2013 | -0.7135M |
| June 30, 2013 | -0.5718M |
| March 31, 2013 | -0.551M |
| December 31, 2012 | -0.4259M |
| September 30, 2012 | -0.538M |
| June 30, 2012 | -0.6293M |
| March 31, 2012 | -0.4002M |
| December 31, 2011 | -0.4238M |
| September 30, 2011 | -0.3505M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.00M
Minimum
Dec 2022
-1.572M
Maximum
Mar 2021
-2.835M
Average
-2.653M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| INVO Bioscience Inc | -0.7149M |
| EyePoint Pharmaceuticals Inc | -31.17M |
| Hepion Pharmaceuticals Inc | -9.002M |
| Aileron Therapeutics Inc | -10.39M |
| Protara Therapeutics Inc | -10.38M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.514M |
| Free Cash Flow | -11.54M |
| Free Cash Flow Per Share (Quarterly) | -2.963 |
| Free Cash Flow Yield | -1.12K% |